View Financial HealthKaneka 배당 및 자사주 매입배당 기준 점검 3/6Kaneka 수익으로 충분히 충당되는 현재 수익률 2.96% 보유한 배당금 지급 회사입니다.핵심 정보3.0%배당 수익률3.9%자사주 매입 수익률총 주주 수익률6.9%미래 배당 수익률3.3%배당 성장률4.5%다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향36%최근 배당 및 자사주 매입 업데이트Upcoming Dividend • Mar 23Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 08 June 2026. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).분석 기사 • Feb 16Kaneka (TSE:4118) Has Announced A Dividend Of ¥80.00The board of Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th...분석 기사 • Dec 07Kaneka's (TSE:4118) Dividend Will Be ¥80.00Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th of June. This...Declared Dividend • Dec 06First half dividend of JP¥80.00 announcedShareholders will receive a dividend of JP¥80.00. Ex-date: 30th March 2026 Payment date: 8th June 2026 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (36% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 37% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Upcoming Dividend • Sep 22Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 05 December 2025. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%).분석 기사 • Sep 01Kaneka's (TSE:4118) Shareholders Will Receive A Bigger Dividend Than Last YearKaneka Corporation's ( TSE:4118 ) dividend will be increasing from last year's payment of the same period to ¥80.00 on...모든 업데이트 보기Recent updates분석 기사 • May 21We Think You Should Be Aware Of Some Concerning Factors In Kaneka's (TSE:4118) EarningsKaneka Corporation's ( TSE:4118 ) healthy profit numbers didn't contain any surprises for investors. We believe that...Reported Earnings • May 18Full year 2026 earnings: EPS exceeds analyst expectationsFull year 2026 results: EPS: JP¥501 (up from JP¥401 in FY 2025). Revenue: JP¥811.6b (flat on FY 2025). Net income: JP¥31.0b (up 22% from FY 2025). Profit margin: 3.8% (up from 3.1% in FY 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.0%. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.공시 • May 14+ 1 more updateKaneka Corporation, Annual General Meeting, Jun 26, 2026Kaneka Corporation, Annual General Meeting, Jun 26, 2026.Buy Or Sell Opportunity • Apr 13Now 20% undervaluedOver the last 90 days, the stock has risen 10% to JP¥5,038. The fair value is estimated to be JP¥6,311, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.2% over the last 3 years. Earnings per share has grown by 12%. For the next 3 years, revenue is forecast to grow by 2.7% per annum. Earnings are also forecast to grow by 5.4% per annum over the same time period.Upcoming Dividend • Mar 23Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 08 June 2026. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).공시 • Mar 18Kaneka Corporation to Report Fiscal Year 2026 Results on May 14, 2026Kaneka Corporation announced that they will report fiscal year 2026 results on May 14, 2026분석 기사 • Feb 16Kaneka (TSE:4118) Has Announced A Dividend Of ¥80.00The board of Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th...분석 기사 • Feb 12Kaneka Corporation (TSE:4118) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?Investors in Kaneka Corporation ( TSE:4118 ) had a good week, as its shares rose 2.8% to close at JP¥5,041 following...Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥121 (vs JP¥120 in 3Q 2025)Third quarter 2026 results: EPS: JP¥121. Revenue: JP¥200.9b (down 3.0% from 3Q 2025). Net income: JP¥7.39b (down 2.4% from 3Q 2025). Profit margin: 3.7% (in line with 3Q 2025). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan.분석 기사 • Jan 15Calculating The Intrinsic Value Of Kaneka Corporation (TSE:4118)Key Insights Using the 2 Stage Free Cash Flow to Equity, Kaneka fair value estimate is JP¥5,711 Kaneka's JP¥4,640 share...분석 기사 • Dec 07Kaneka's (TSE:4118) Dividend Will Be ¥80.00Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th of June. This...Declared Dividend • Dec 06First half dividend of JP¥80.00 announcedShareholders will receive a dividend of JP¥80.00. Ex-date: 30th March 2026 Payment date: 8th June 2026 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (36% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 37% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Dec 02Kaneka Corporation to Report Q3, 2026 Results on Feb 10, 2026Kaneka Corporation announced that they will report Q3, 2026 results on Feb 10, 2026분석 기사 • Nov 19Impressive Earnings May Not Tell The Whole Story For Kaneka (TSE:4118)Kaneka Corporation ( TSE:4118 ) announced strong profits, but the stock was stagnant. Our analysis suggests that...Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: JP¥109 (vs JP¥49.73 in 2Q 2025)Second quarter 2026 results: EPS: JP¥109 (up from JP¥49.73 in 2Q 2025). Revenue: JP¥198.7b (flat on 2Q 2025). Net income: JP¥6.79b (up 117% from 2Q 2025). Profit margin: 3.4% (up from 1.6% in 2Q 2025). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year.공시 • Nov 12+ 1 more updateKaneka Corporation Revises Consolidated Earnings Guidance for the Fiscal Year from April 1, 2025 to March 31, 2026Kaneka Corporation revised consolidated earnings guidance for the fiscal year from April 1, 2025 to March 31, 2026. For the year, the company expects net sales of ¥800,000 million compared to previous guidance of ¥820,000 million, operating income of ¥37,000 million compared to previous guidance of ¥42,000 million, net income attributable to owners of parent of ¥33,000 million compared to previous guidance of ¥33,000 million and net income per share of ¥534.03 compared to previous guidance of ¥524.36.공시 • Nov 10Kaneka Expands Global Reach with i-ED COIL Launch in EuropeKaneka Corporation has begun sales of its i-ED COIL, a brain aneurysm embolization coil in Europe as of October. The product obtained EC certification under an EU Medical Device Regulation in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. The i-ED COIL provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes. Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily. Kaneka is expanding its business in a wide range of fields, which include devices for the treatment of cardiac, peripheral vascular, and cerebrovascular diseases, as well as medical devices used in the treatment of gastrointestinal tract diseases. Looking ahead, company aim to strengthen the global reach of products such as i-ED COIL and achieve sales of JPY 300 billion by 2030 in the Health Care Solution Unit including these medical businesses.Upcoming Dividend • Sep 22Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 05 December 2025. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%).분석 기사 • Sep 01Kaneka's (TSE:4118) Shareholders Will Receive A Bigger Dividend Than Last YearKaneka Corporation's ( TSE:4118 ) dividend will be increasing from last year's payment of the same period to ¥80.00 on...공시 • Sep 01Kaneka Corporation to Report Q2, 2026 Results on Nov 12, 2025Kaneka Corporation announced that they will report Q2, 2026 results on Nov 12, 2025Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: JP¥67.73 (vs JP¥110 in 1Q 2025)First quarter 2026 results: EPS: JP¥67.73 (down from JP¥110 in 1Q 2025). Revenue: JP¥198.7b (flat on 1Q 2025). Net income: JP¥4.26b (down 39% from 1Q 2025). Profit margin: 2.1% (down from 3.5% in 1Q 2025). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 7% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Jul 24Kaneka's (TSE:4118) Shareholders Will Receive A Bigger Dividend Than Last YearThe board of Kaneka Corporation ( TSE:4118 ) has announced that it will be paying its dividend of ¥80.00 on the 5th of...분석 기사 • Jul 10Kaneka (TSE:4118) Is Increasing Its Dividend To ¥80.00Kaneka Corporation ( TSE:4118 ) has announced that it will be increasing its dividend from last year's comparable...Declared Dividend • Jul 09Final dividend of JP¥80.00 announcedShareholders will receive a dividend of JP¥80.00. Ex-date: 29th September 2025 Payment date: 5th December 2025 Dividend yield will be 3.7%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 48% over the next 3 years, which should provide support to the dividend and adequate earnings cover.공시 • Jun 13Kaneka Corporation to Report Q1, 2026 Results on Aug 08, 2025Kaneka Corporation announced that they will report Q1, 2026 results on Aug 08, 2025Reported Earnings • May 19Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: JP¥401 (up from JP¥358 in FY 2024). Revenue: JP¥807.2b (up 5.9% from FY 2024). Net income: JP¥25.3b (up 9.0% from FY 2024). Profit margin: 3.1% (up from 3.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.0%. Revenue is forecast to grow 4.0% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 4% per year.공시 • May 16Kaneka Corporation (TSE:4118) announces an Equity Buyback for 3,000,000 shares, representing 4.77% for ¥12,000 million.Kaneka Corporation (TSE:4118) announces a share repurchase program. Under the program, the company will repurchase 3,000,000 shares, representing 4.77% of the outstanding shares for ¥12,000 million. The purpose of the program is to improve shareholder value and implement flexible capital policies in response to changes in the business environment. The program will run until March 29, 2026. As of April 30, 2025, the company had 62,934,292 shares outstanding and 3,065,708 shares in treasury.공시 • May 14Kaneka Corporation, Annual General Meeting, Jun 27, 2025Kaneka Corporation, Annual General Meeting, Jun 27, 2025.분석 기사 • Apr 28There's No Escaping Kaneka Corporation's (TSE:4118) Muted EarningsWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") above 13x, you may consider Kaneka...분석 기사 • Apr 09Is Kaneka (TSE:4118) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥3,214, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Japan. Total returns to shareholders of 2.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥3,750 per share.분석 기사 • Mar 21Kaneka (TSE:4118) Will Pay A Dividend Of ¥60.00Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥60.00 per share on the 6th of June. This...공시 • Mar 21Kaneka Corporation to Report Fiscal Year 2025 Results on May 14, 2025Kaneka Corporation announced that they will report fiscal year 2025 results on May 14, 2025Upcoming Dividend • Mar 21Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 06 June 2025. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.6%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).Declared Dividend • Feb 18Dividend of JP¥60.00 announcedShareholders will receive a dividend of JP¥60.00. Ex-date: 28th March 2025 Payment date: 6th June 2025 Dividend yield will be 3.2%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (27% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 10% over the next 2 years, which should provide support to the dividend and adequate earnings cover.분석 기사 • Feb 18Kaneka (TSE:4118) Is Due To Pay A Dividend Of ¥60.00The board of Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥60.00 per share on the 6th...Reported Earnings • Feb 15Third quarter 2025 earnings released: EPS: JP¥120 (vs JP¥69.95 in 3Q 2024)Third quarter 2025 results: EPS: JP¥120 (up from JP¥69.95 in 3Q 2024). Revenue: JP¥207.1b (up 6.4% from 3Q 2024). Net income: JP¥7.57b (up 67% from 3Q 2024). Profit margin: 3.7% (up from 2.3% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has remained flat.분석 기사 • Jan 27Kaneka Corporation's (TSE:4118) Shares Lagging The Market But So Is The BusinessWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") above 14x, you may consider Kaneka...공시 • Jan 09Kaneka Corporation (TSE:4118) acquired 96.80% stake in EndoStream Medical Ltd.Kaneka Corporation (TSE:4118) acquired 96.80% stake in EndoStream Medical Ltd on December 23, 2024. By combining Kaneka's manufacturing and ESM's technology, we will jointly develop new medical devices, mainly for cerebrovascular treatment, in addition to the Nautilus device for aneurysm treatment currently under development. We aim to achieve sales of over ¥20 billion by 2030. Kaneka Corporation (TSE:4118) completed the acquisition of 96.80% stake in EndoStream Medical Ltd on December 23, 2024.공시 • Dec 21Kaneka Corporation to Report Q3, 2025 Results on Feb 13, 2025Kaneka Corporation announced that they will report Q3, 2025 results on Feb 13, 2025분석 기사 • Nov 20Kaneka's (TSE:4118) Earnings Are Weaker Than They SeemInvestors were disappointed with Kaneka Corporation's ( TSE:4118 ) earnings, despite the strong profit numbers. We did...Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: JP¥49.73 (vs JP¥71.73 in 2Q 2024)Second quarter 2025 results: EPS: JP¥49.73 (down from JP¥71.73 in 2Q 2024). Revenue: JP¥197.6b (up 5.4% from 2Q 2024). Net income: JP¥3.13b (down 33% from 2Q 2024). Profit margin: 1.6% (down from 2.5% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 5% per year.분석 기사 • Nov 13Kaneka's (TSE:4118) Returns Have Hit A WallWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...Upcoming Dividend • Sep 20Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).공시 • Sep 18Kaneka Corporation to Report Q2, 2025 Results on Nov 12, 2024Kaneka Corporation announced that they will report Q2, 2025 results on Nov 12, 2024Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to JP¥3,317, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 12x in the Chemicals industry in Japan. Total loss to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥2,772 per share.분석 기사 • Aug 03These 4 Measures Indicate That Kaneka (TSE:4118) Is Using Debt ExtensivelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Jul 12Kaneka Corporation (TSE:4118) Might Not Be As Mispriced As It LooksKaneka Corporation's ( TSE:4118 ) price-to-earnings (or "P/E") ratio of 11.8x might make it look like a buy right now...공시 • Jun 18Kaneka Corporation to Report Q1, 2025 Results on Aug 08, 2024Kaneka Corporation announced that they will report Q1, 2025 results on Aug 08, 2024분석 기사 • May 22Kaneka's (TSE:4118) Profits May Not Reveal Underlying IssuesThe market shrugged off Kaneka Corporation's ( TSE:4118 ) solid earnings report. We did some digging and believe...Reported Earnings • May 18Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: JP¥358 (up from JP¥350 in FY 2023). Revenue: JP¥762.3b (flat on FY 2023). Net income: JP¥23.2b (flat on FY 2023). Profit margin: 3.0% (in line with FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 5.9%. Revenue is forecast to grow 4.6% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 4% per year.공시 • May 16Kaneka Corporation, Annual General Meeting, Jun 27, 2024Kaneka Corporation, Annual General Meeting, Jun 27, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥55.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 12 June 2024. Payout ratio is a comfortable 41% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).분석 기사 • Mar 21Investors Aren't Entirely Convinced By Kaneka Corporation's (TSE:4118) EarningsThere wouldn't be many who think Kaneka Corporation's ( TSE:4118 ) price-to-earnings (or "P/E") ratio of 14.1x is worth...공시 • Mar 13Kaneka Corporation to Report Fiscal Year 2024 Results on May 14, 2024Kaneka Corporation announced that they will report fiscal year 2024 results on May 14, 2024Major Estimate Revision • Mar 04Consensus EPS estimates fall by 12%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥395 to JP¥346 per share. Revenue forecast steady at JP¥770.1b. Net income forecast to grow 40% next year vs 20% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥4,055 unchanged from last update. Share price was steady at JP¥3,684 over the past week.Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: JP¥69.95 (vs JP¥34.88 in 3Q 2023)Third quarter 2024 results: EPS: JP¥69.95 (up from JP¥34.88 in 3Q 2023). Revenue: JP¥194.6b (up 4.3% from 3Q 2023). Net income: JP¥4.54b (up 96% from 3Q 2023). Profit margin: 2.3% (up from 1.2% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 5% per year.Buy Or Sell Opportunity • Jan 26Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.5% to JP¥3,579. The fair value is estimated to be JP¥4,513, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 7.0%. Revenue is forecast to grow by 9.1% in 2 years. Earnings are forecast to grow by 90% in the next 2 years.Buying Opportunity • Jan 12Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.8%. The fair value is estimated to be JP¥4,560, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 7.0%. Revenue is forecast to grow by 8.9% in 2 years. Earnings is forecast to grow by 92% in the next 2 years.공시 • Nov 30Kaneka Corporation to Report Q3, 2024 Results on Feb 08, 2024Kaneka Corporation announced that they will report Q3, 2024 results on Feb 08, 2024Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: JP¥71.73 (vs JP¥91.80 in 2Q 2023)Second quarter 2024 results: EPS: JP¥71.73 (down from JP¥91.80 in 2Q 2023). Revenue: JP¥187.4b (flat on 2Q 2023). Net income: JP¥4.66b (down 23% from 2Q 2023). Profit margin: 2.5% (down from 3.2% in 2Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year.Upcoming Dividend • Sep 21Upcoming dividend of JP¥55.00 per share at 2.7% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. Payout ratio is a comfortable 43% but the company is not cash flow positive. Trailing yield: 2.7%. Lower than top quartile of Japanese dividend payers (3.3%). In line with average of industry peers (2.5%).공시 • Sep 13Kaneka Corporation to Report Q2, 2024 Results on Nov 09, 2023Kaneka Corporation announced that they will report Q2, 2024 results on Nov 09, 2023New Risk • Aug 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 4.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.2% net profit margin).Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥65.35 (vs JP¥161 in 1Q 2023)First quarter 2024 results: EPS: JP¥65.35 (down from JP¥161 in 1Q 2023). Revenue: JP¥182.7b (down 5.2% from 1Q 2023). Net income: JP¥4.24b (down 60% from 1Q 2023). Profit margin: 2.3% (down from 5.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 13% per year.공시 • Jun 15Kaneka Corporation to Report Q1, 2024 Results on Aug 09, 2023Kaneka Corporation announced that they will report Q1, 2024 results on Aug 09, 2023Reported Earnings • May 18Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: JP¥350 (down from JP¥406 in FY 2022). Revenue: JP¥755.8b (up 9.3% from FY 2022). Net income: JP¥23.0b (down 13% from FY 2022). Profit margin: 3.0% (down from 3.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 4.7%. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.공시 • May 17Kaneka Corporation, Annual General Meeting, Jun 29, 2023Kaneka Corporation, Annual General Meeting, Jun 29, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥55.00 per share at 3.3% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 13 June 2023. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: JP¥34.87 (vs JP¥111 in 3Q 2022)Third quarter 2023 results: EPS: JP¥34.87 (down from JP¥111 in 3Q 2022). Revenue: JP¥186.5b (up 4.5% from 3Q 2022). Net income: JP¥2.32b (down 68% from 3Q 2022). Profit margin: 1.2% (down from 4.1% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.Price Target Changed • Jan 26Price target decreased by 8.8% to JP¥4,021Down from JP¥4,408, the current price target is an average from 7 analysts. New target price is 19% above last closing price of JP¥3,375. Stock is down 6.3% over the past year. The company is forecast to post earnings per share of JP¥423 for next year compared to JP¥406 last year.공시 • Dec 17Kaneka Corporation to Report Q3, 2023 Results on Feb 08, 2023Kaneka Corporation announced that they will report Q3, 2023 results on Feb 08, 2023Price Target Changed • Dec 13Price target decreased to JP¥4,408Down from JP¥4,920, the current price target is an average from 6 analysts. New target price is 31% above last closing price of JP¥3,360. Stock is down 11% over the past year. The company is forecast to post earnings per share of JP¥414 for next year compared to JP¥406 last year.Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. 2 highly experienced directors. 4 independent directors (8 non-independent directors). Independent Director Yuko Sasakawa was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥91.80 (vs JP¥107 in 2Q 2022)Second quarter 2023 results: EPS: JP¥91.80 (down from JP¥107 in 2Q 2022). Revenue: JP¥187.9b (up 13% from 2Q 2022). Net income: JP¥6.05b (down 14% from 2Q 2022). Profit margin: 3.2% (down from 4.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥55.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 06 December 2022. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.9%).Reported Earnings • Aug 12First quarter 2023 earnings released: EPS: JP¥161 (vs JP¥119 in 1Q 2022)First quarter 2023 results: EPS: JP¥161 (up from JP¥119 in 1Q 2022). Revenue: JP¥192.7b (up 17% from 1Q 2022). Net income: JP¥10.5b (up 36% from 1Q 2022). Profit margin: 5.5% (up from 4.7% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 3.2%, compared to a 9.6% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.Reported Earnings • May 16Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: JP¥406 (up from JP¥243 in FY 2021). Revenue: JP¥691.5b (up 20% from FY 2021). Net income: JP¥26.5b (up 67% from FY 2021). Profit margin: 3.8% (up from 2.7% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 7.3%, compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 8 non-independent directors. Managing Executive Officer & Director Katsunobu Doro was the last director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Upcoming Dividend • Mar 23Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 06 June 2022. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.6%).Reported Earnings • Feb 09Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: JP¥111 (up from JP¥110 in 3Q 2021). Revenue: JP¥178.4b (up 15% from 3Q 2021). Net income: JP¥7.26b (up 1.0% from 3Q 2021). Profit margin: 4.1% (down from 4.6% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Over the next year, revenue is forecast to stay flat compared to a 6.6% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥107 (vs JP¥31.26 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥166.2b (up 19% from 2Q 2021). Net income: JP¥7.01b (up 244% from 2Q 2021). Profit margin: 4.2% (up from 1.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year and the company’s share price has also fallen by 2% per year.Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.9%).Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥119 (vs JP¥6.70 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥164.1b (up 30% from 1Q 2021). Net income: JP¥7.76b (up JP¥7.32b from 1Q 2021). Profit margin: 4.7% (up from 0.3% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.Price Target Changed • Jul 10Price target increased to JP¥5,056Up from JP¥4,720, the current price target is an average from 5 analysts. New target price is 15% above last closing price of JP¥4,400. Stock is up 71% over the past year.Reported Earnings • May 16Full year 2021 earnings released: EPS JP¥243 (vs JP¥215 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥577.4b (down 4.0% from FY 2020). Net income: JP¥15.8b (up 13% from FY 2020). Profit margin: 2.7% (up from 2.3% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 11 June 2021. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.8%).Price Target Changed • Mar 06Price target raised to JP¥4,050Up from JP¥3,650, the current price target is an average from 4 analysts. The new target price is 11% below the current share price of JP¥4,535. As of last close, the stock is up 64% over the past year.Price Target Changed • Mar 02Price target raised to JP¥3,770Up from JP¥3,464, the current price target is an average from 4 analysts. The new target price is 9.8% below the current share price of JP¥4,180. As of last close, the stock is up 46% over the past year.Is New 90 Day High Low • Feb 24New 90-day high: JP¥4,340The company is up 34% from its price of JP¥3,250 on 26 November 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥2,998 per share.Major Estimate Revision • Feb 23Analysts update estimatesThe 2021 consensus earning per share (EPS) estimate increased from JP¥164 to JP¥181. Revenue estimate for the same period was approximately flat at JP¥565.9b. Net income is expected to grow by 10.0% next year compared to 17% growth forecast for the Chemicals industry in Japan. The consensus price target increased from JP¥3,464 to JP¥3,650. Share price stayed mostly flat at JP¥4,275 over the past week.Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS JP¥110 (vs JP¥48.85 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥154.8b (up 1.4% from 3Q 2020). Net income: JP¥7.18b (up 125% from 3Q 2020). Profit margin: 4.6% (up from 2.1% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Analyst Estimate Surprise Post Earnings • Feb 11Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 4.7%. Earnings per share (EPS) also surpassed analyst estimates by 1.6%. Over the next year, revenue is forecast to grow 3.3%, compared to a 6.5% growth forecast for the Chemicals industry in Japan.Is New 90 Day High Low • Jan 27New 90-day high: JP¥3,795The company is up 25% from its price of JP¥3,025 on 29 October 2020. The Japanese market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥1,364 per share.Is New 90 Day High Low • Jan 12New 90-day high: JP¥3,700The company is up 20% from its price of JP¥3,090 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥1,350 per share.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 4118 의 배당금 지급은 지난 10 년 동안 휘발성이었습니다.배당금 증가: 4118 의 배당금 지급은 지난 10 년 동안 증가했습니다.배당 수익률 vs 시장Kaneka 배당 수익률 vs 시장4118의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (4118)3.0%시장 하위 25% (JP)1.8%시장 상위 25% (JP)3.9%업계 평균 (Chemicals)2.2%분석가 예측 (4118) (최대 3년)3.3%주목할만한 배당금: 4118 의 배당금( 2.96% )은 JP 시장에서 배당금 지급자의 하위 25%( 1.79% )보다 높습니다.고배당: 4118 의 배당금( 2.96% )은 JP 시장에서 배당금 지급자의 상위 25%( 3.9% )와 비교해 낮습니다.주주 대상 이익 배당수익 보장: 합리적으로 낮은 지불 비율 ( 36% )로 4118 의 배당금 지급은 수익으로 충분히 충당됩니다.주주 현금 배당현금 흐름 범위: 4118 배당금을 지급하고 있지만 회사에는 잉여현금흐름이 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YJP 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/06/08 06:37종가2026/06/08 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Kaneka Corporation는 16명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Kyoji ChibaBofA Global ResearchTakao KanaiCitigroup IncKeita IkedaDaiwa Securities Co. Ltd.13명의 분석가 더 보기
Upcoming Dividend • Mar 23Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 08 June 2026. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
분석 기사 • Feb 16Kaneka (TSE:4118) Has Announced A Dividend Of ¥80.00The board of Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th...
분석 기사 • Dec 07Kaneka's (TSE:4118) Dividend Will Be ¥80.00Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th of June. This...
Declared Dividend • Dec 06First half dividend of JP¥80.00 announcedShareholders will receive a dividend of JP¥80.00. Ex-date: 30th March 2026 Payment date: 8th June 2026 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (36% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 37% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 05 December 2025. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%).
분석 기사 • Sep 01Kaneka's (TSE:4118) Shareholders Will Receive A Bigger Dividend Than Last YearKaneka Corporation's ( TSE:4118 ) dividend will be increasing from last year's payment of the same period to ¥80.00 on...
분석 기사 • May 21We Think You Should Be Aware Of Some Concerning Factors In Kaneka's (TSE:4118) EarningsKaneka Corporation's ( TSE:4118 ) healthy profit numbers didn't contain any surprises for investors. We believe that...
Reported Earnings • May 18Full year 2026 earnings: EPS exceeds analyst expectationsFull year 2026 results: EPS: JP¥501 (up from JP¥401 in FY 2025). Revenue: JP¥811.6b (flat on FY 2025). Net income: JP¥31.0b (up 22% from FY 2025). Profit margin: 3.8% (up from 3.1% in FY 2025). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.0%. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
공시 • May 14+ 1 more updateKaneka Corporation, Annual General Meeting, Jun 26, 2026Kaneka Corporation, Annual General Meeting, Jun 26, 2026.
Buy Or Sell Opportunity • Apr 13Now 20% undervaluedOver the last 90 days, the stock has risen 10% to JP¥5,038. The fair value is estimated to be JP¥6,311, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 3.2% over the last 3 years. Earnings per share has grown by 12%. For the next 3 years, revenue is forecast to grow by 2.7% per annum. Earnings are also forecast to grow by 5.4% per annum over the same time period.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 08 June 2026. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.5%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
공시 • Mar 18Kaneka Corporation to Report Fiscal Year 2026 Results on May 14, 2026Kaneka Corporation announced that they will report fiscal year 2026 results on May 14, 2026
분석 기사 • Feb 16Kaneka (TSE:4118) Has Announced A Dividend Of ¥80.00The board of Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th...
분석 기사 • Feb 12Kaneka Corporation (TSE:4118) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?Investors in Kaneka Corporation ( TSE:4118 ) had a good week, as its shares rose 2.8% to close at JP¥5,041 following...
Reported Earnings • Feb 11Third quarter 2026 earnings released: EPS: JP¥121 (vs JP¥120 in 3Q 2025)Third quarter 2026 results: EPS: JP¥121. Revenue: JP¥200.9b (down 3.0% from 3Q 2025). Net income: JP¥7.39b (down 2.4% from 3Q 2025). Profit margin: 3.7% (in line with 3Q 2025). Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan.
분석 기사 • Jan 15Calculating The Intrinsic Value Of Kaneka Corporation (TSE:4118)Key Insights Using the 2 Stage Free Cash Flow to Equity, Kaneka fair value estimate is JP¥5,711 Kaneka's JP¥4,640 share...
분석 기사 • Dec 07Kaneka's (TSE:4118) Dividend Will Be ¥80.00Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥80.00 per share on the 8th of June. This...
Declared Dividend • Dec 06First half dividend of JP¥80.00 announcedShareholders will receive a dividend of JP¥80.00. Ex-date: 30th March 2026 Payment date: 8th June 2026 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (36% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 37% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Dec 02Kaneka Corporation to Report Q3, 2026 Results on Feb 10, 2026Kaneka Corporation announced that they will report Q3, 2026 results on Feb 10, 2026
분석 기사 • Nov 19Impressive Earnings May Not Tell The Whole Story For Kaneka (TSE:4118)Kaneka Corporation ( TSE:4118 ) announced strong profits, but the stock was stagnant. Our analysis suggests that...
Reported Earnings • Nov 14Second quarter 2026 earnings released: EPS: JP¥109 (vs JP¥49.73 in 2Q 2025)Second quarter 2026 results: EPS: JP¥109 (up from JP¥49.73 in 2Q 2025). Revenue: JP¥198.7b (flat on 2Q 2025). Net income: JP¥6.79b (up 117% from 2Q 2025). Profit margin: 3.4% (up from 1.6% in 2Q 2025). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year.
공시 • Nov 12+ 1 more updateKaneka Corporation Revises Consolidated Earnings Guidance for the Fiscal Year from April 1, 2025 to March 31, 2026Kaneka Corporation revised consolidated earnings guidance for the fiscal year from April 1, 2025 to March 31, 2026. For the year, the company expects net sales of ¥800,000 million compared to previous guidance of ¥820,000 million, operating income of ¥37,000 million compared to previous guidance of ¥42,000 million, net income attributable to owners of parent of ¥33,000 million compared to previous guidance of ¥33,000 million and net income per share of ¥534.03 compared to previous guidance of ¥524.36.
공시 • Nov 10Kaneka Expands Global Reach with i-ED COIL Launch in EuropeKaneka Corporation has begun sales of its i-ED COIL, a brain aneurysm embolization coil in Europe as of October. The product obtained EC certification under an EU Medical Device Regulation in July and will be distributed primarily in Europe through Kaneka Medical Europe N.V. The i-ED COIL provides world-class flexibility, enabled by its specialized wire thickness and structural features. This flexibility enables coils to be packed more densely within aneurysms than conventional products and allows treatment of aneurysms with irregular shapes. Its role in reducing the risk of aneurysm rupture is highly regarded by physicians, and since its launch in the Japanese market in 2019, sales have continued to grow steadily. Kaneka is expanding its business in a wide range of fields, which include devices for the treatment of cardiac, peripheral vascular, and cerebrovascular diseases, as well as medical devices used in the treatment of gastrointestinal tract diseases. Looking ahead, company aim to strengthen the global reach of products such as i-ED COIL and achieve sales of JPY 300 billion by 2030 in the Health Care Solution Unit including these medical businesses.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥80.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 05 December 2025. Payout ratio is a comfortable 36% but the company is not cash flow positive. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.6%).
분석 기사 • Sep 01Kaneka's (TSE:4118) Shareholders Will Receive A Bigger Dividend Than Last YearKaneka Corporation's ( TSE:4118 ) dividend will be increasing from last year's payment of the same period to ¥80.00 on...
공시 • Sep 01Kaneka Corporation to Report Q2, 2026 Results on Nov 12, 2025Kaneka Corporation announced that they will report Q2, 2026 results on Nov 12, 2025
Reported Earnings • Aug 09First quarter 2026 earnings released: EPS: JP¥67.73 (vs JP¥110 in 1Q 2025)First quarter 2026 results: EPS: JP¥67.73 (down from JP¥110 in 1Q 2025). Revenue: JP¥198.7b (flat on 1Q 2025). Net income: JP¥4.26b (down 39% from 1Q 2025). Profit margin: 2.1% (down from 3.5% in 1Q 2025). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 7% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Jul 24Kaneka's (TSE:4118) Shareholders Will Receive A Bigger Dividend Than Last YearThe board of Kaneka Corporation ( TSE:4118 ) has announced that it will be paying its dividend of ¥80.00 on the 5th of...
분석 기사 • Jul 10Kaneka (TSE:4118) Is Increasing Its Dividend To ¥80.00Kaneka Corporation ( TSE:4118 ) has announced that it will be increasing its dividend from last year's comparable...
Declared Dividend • Jul 09Final dividend of JP¥80.00 announcedShareholders will receive a dividend of JP¥80.00. Ex-date: 29th September 2025 Payment date: 5th December 2025 Dividend yield will be 3.7%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (32% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 7.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 48% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
공시 • Jun 13Kaneka Corporation to Report Q1, 2026 Results on Aug 08, 2025Kaneka Corporation announced that they will report Q1, 2026 results on Aug 08, 2025
Reported Earnings • May 19Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: EPS: JP¥401 (up from JP¥358 in FY 2024). Revenue: JP¥807.2b (up 5.9% from FY 2024). Net income: JP¥25.3b (up 9.0% from FY 2024). Profit margin: 3.1% (up from 3.0% in FY 2024). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.0%. Revenue is forecast to grow 4.0% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has increased by 4% per year.
공시 • May 16Kaneka Corporation (TSE:4118) announces an Equity Buyback for 3,000,000 shares, representing 4.77% for ¥12,000 million.Kaneka Corporation (TSE:4118) announces a share repurchase program. Under the program, the company will repurchase 3,000,000 shares, representing 4.77% of the outstanding shares for ¥12,000 million. The purpose of the program is to improve shareholder value and implement flexible capital policies in response to changes in the business environment. The program will run until March 29, 2026. As of April 30, 2025, the company had 62,934,292 shares outstanding and 3,065,708 shares in treasury.
공시 • May 14Kaneka Corporation, Annual General Meeting, Jun 27, 2025Kaneka Corporation, Annual General Meeting, Jun 27, 2025.
분석 기사 • Apr 28There's No Escaping Kaneka Corporation's (TSE:4118) Muted EarningsWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") above 13x, you may consider Kaneka...
분석 기사 • Apr 09Is Kaneka (TSE:4118) A Risky Investment?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to JP¥3,214, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 10x in the Chemicals industry in Japan. Total returns to shareholders of 2.3% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥3,750 per share.
분석 기사 • Mar 21Kaneka (TSE:4118) Will Pay A Dividend Of ¥60.00Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥60.00 per share on the 6th of June. This...
공시 • Mar 21Kaneka Corporation to Report Fiscal Year 2025 Results on May 14, 2025Kaneka Corporation announced that they will report fiscal year 2025 results on May 14, 2025
Upcoming Dividend • Mar 21Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 06 June 2025. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.6%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.6%).
Declared Dividend • Feb 18Dividend of JP¥60.00 announcedShareholders will receive a dividend of JP¥60.00. Ex-date: 28th March 2025 Payment date: 6th June 2025 Dividend yield will be 3.2%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (27% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 5.8% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 10% over the next 2 years, which should provide support to the dividend and adequate earnings cover.
분석 기사 • Feb 18Kaneka (TSE:4118) Is Due To Pay A Dividend Of ¥60.00The board of Kaneka Corporation ( TSE:4118 ) has announced that it will pay a dividend of ¥60.00 per share on the 6th...
Reported Earnings • Feb 15Third quarter 2025 earnings released: EPS: JP¥120 (vs JP¥69.95 in 3Q 2024)Third quarter 2025 results: EPS: JP¥120 (up from JP¥69.95 in 3Q 2024). Revenue: JP¥207.1b (up 6.4% from 3Q 2024). Net income: JP¥7.57b (up 67% from 3Q 2024). Profit margin: 3.7% (up from 2.3% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has remained flat.
분석 기사 • Jan 27Kaneka Corporation's (TSE:4118) Shares Lagging The Market But So Is The BusinessWhen close to half the companies in Japan have price-to-earnings ratios (or "P/E's") above 14x, you may consider Kaneka...
공시 • Jan 09Kaneka Corporation (TSE:4118) acquired 96.80% stake in EndoStream Medical Ltd.Kaneka Corporation (TSE:4118) acquired 96.80% stake in EndoStream Medical Ltd on December 23, 2024. By combining Kaneka's manufacturing and ESM's technology, we will jointly develop new medical devices, mainly for cerebrovascular treatment, in addition to the Nautilus device for aneurysm treatment currently under development. We aim to achieve sales of over ¥20 billion by 2030. Kaneka Corporation (TSE:4118) completed the acquisition of 96.80% stake in EndoStream Medical Ltd on December 23, 2024.
공시 • Dec 21Kaneka Corporation to Report Q3, 2025 Results on Feb 13, 2025Kaneka Corporation announced that they will report Q3, 2025 results on Feb 13, 2025
분석 기사 • Nov 20Kaneka's (TSE:4118) Earnings Are Weaker Than They SeemInvestors were disappointed with Kaneka Corporation's ( TSE:4118 ) earnings, despite the strong profit numbers. We did...
Reported Earnings • Nov 15Second quarter 2025 earnings released: EPS: JP¥49.73 (vs JP¥71.73 in 2Q 2024)Second quarter 2025 results: EPS: JP¥49.73 (down from JP¥71.73 in 2Q 2024). Revenue: JP¥197.6b (up 5.4% from 2Q 2024). Net income: JP¥3.13b (down 33% from 2Q 2024). Profit margin: 1.6% (down from 2.5% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 5% per year.
분석 기사 • Nov 13Kaneka's (TSE:4118) Returns Have Hit A WallWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Amongst...
Upcoming Dividend • Sep 20Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Payout ratio is a comfortable 27% but the company is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).
공시 • Sep 18Kaneka Corporation to Report Q2, 2025 Results on Nov 12, 2024Kaneka Corporation announced that they will report Q2, 2025 results on Nov 12, 2024
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to JP¥3,317, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 12x in the Chemicals industry in Japan. Total loss to shareholders of 19% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥2,772 per share.
분석 기사 • Aug 03These 4 Measures Indicate That Kaneka (TSE:4118) Is Using Debt ExtensivelyDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Jul 12Kaneka Corporation (TSE:4118) Might Not Be As Mispriced As It LooksKaneka Corporation's ( TSE:4118 ) price-to-earnings (or "P/E") ratio of 11.8x might make it look like a buy right now...
공시 • Jun 18Kaneka Corporation to Report Q1, 2025 Results on Aug 08, 2024Kaneka Corporation announced that they will report Q1, 2025 results on Aug 08, 2024
분석 기사 • May 22Kaneka's (TSE:4118) Profits May Not Reveal Underlying IssuesThe market shrugged off Kaneka Corporation's ( TSE:4118 ) solid earnings report. We did some digging and believe...
Reported Earnings • May 18Full year 2024 earnings: EPS exceeds analyst expectationsFull year 2024 results: EPS: JP¥358 (up from JP¥350 in FY 2023). Revenue: JP¥762.3b (flat on FY 2023). Net income: JP¥23.2b (flat on FY 2023). Profit margin: 3.0% (in line with FY 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 5.9%. Revenue is forecast to grow 4.6% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 4% per year.
공시 • May 16Kaneka Corporation, Annual General Meeting, Jun 27, 2024Kaneka Corporation, Annual General Meeting, Jun 27, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥55.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 12 June 2024. Payout ratio is a comfortable 41% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).
분석 기사 • Mar 21Investors Aren't Entirely Convinced By Kaneka Corporation's (TSE:4118) EarningsThere wouldn't be many who think Kaneka Corporation's ( TSE:4118 ) price-to-earnings (or "P/E") ratio of 14.1x is worth...
공시 • Mar 13Kaneka Corporation to Report Fiscal Year 2024 Results on May 14, 2024Kaneka Corporation announced that they will report fiscal year 2024 results on May 14, 2024
Major Estimate Revision • Mar 04Consensus EPS estimates fall by 12%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥395 to JP¥346 per share. Revenue forecast steady at JP¥770.1b. Net income forecast to grow 40% next year vs 20% growth forecast for Chemicals industry in Japan. Consensus price target of JP¥4,055 unchanged from last update. Share price was steady at JP¥3,684 over the past week.
Reported Earnings • Feb 10Third quarter 2024 earnings released: EPS: JP¥69.95 (vs JP¥34.88 in 3Q 2023)Third quarter 2024 results: EPS: JP¥69.95 (up from JP¥34.88 in 3Q 2023). Revenue: JP¥194.6b (up 4.3% from 3Q 2023). Net income: JP¥4.54b (up 96% from 3Q 2023). Profit margin: 2.3% (up from 1.2% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 3% per year whereas the company’s share price has fallen by 5% per year.
Buy Or Sell Opportunity • Jan 26Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.5% to JP¥3,579. The fair value is estimated to be JP¥4,513, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 7.0%. Revenue is forecast to grow by 9.1% in 2 years. Earnings are forecast to grow by 90% in the next 2 years.
Buying Opportunity • Jan 12Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 3.8%. The fair value is estimated to be JP¥4,560, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has grown by 7.0%. Revenue is forecast to grow by 8.9% in 2 years. Earnings is forecast to grow by 92% in the next 2 years.
공시 • Nov 30Kaneka Corporation to Report Q3, 2024 Results on Feb 08, 2024Kaneka Corporation announced that they will report Q3, 2024 results on Feb 08, 2024
Reported Earnings • Nov 10Second quarter 2024 earnings released: EPS: JP¥71.73 (vs JP¥91.80 in 2Q 2023)Second quarter 2024 results: EPS: JP¥71.73 (down from JP¥91.80 in 2Q 2023). Revenue: JP¥187.4b (flat on 2Q 2023). Net income: JP¥4.66b (down 23% from 2Q 2023). Profit margin: 2.5% (down from 3.2% in 2Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 7% per year and the company’s share price has also increased by 7% per year.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥55.00 per share at 2.7% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 05 December 2023. Payout ratio is a comfortable 43% but the company is not cash flow positive. Trailing yield: 2.7%. Lower than top quartile of Japanese dividend payers (3.3%). In line with average of industry peers (2.5%).
공시 • Sep 13Kaneka Corporation to Report Q2, 2024 Results on Nov 09, 2023Kaneka Corporation announced that they will report Q2, 2024 results on Nov 09, 2023
New Risk • Aug 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.2% Last year net profit margin: 4.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.2% net profit margin).
Reported Earnings • Aug 10First quarter 2024 earnings released: EPS: JP¥65.35 (vs JP¥161 in 1Q 2023)First quarter 2024 results: EPS: JP¥65.35 (down from JP¥161 in 1Q 2023). Revenue: JP¥182.7b (down 5.2% from 1Q 2023). Net income: JP¥4.24b (down 60% from 1Q 2023). Profit margin: 2.3% (down from 5.5% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year whereas the company’s share price has increased by 13% per year.
공시 • Jun 15Kaneka Corporation to Report Q1, 2024 Results on Aug 09, 2023Kaneka Corporation announced that they will report Q1, 2024 results on Aug 09, 2023
Reported Earnings • May 18Full year 2023 earnings: EPS misses analyst expectationsFull year 2023 results: EPS: JP¥350 (down from JP¥406 in FY 2022). Revenue: JP¥755.8b (up 9.3% from FY 2022). Net income: JP¥23.0b (down 13% from FY 2022). Profit margin: 3.0% (down from 3.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 4.7%. Revenue is forecast to grow 2.1% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
공시 • May 17Kaneka Corporation, Annual General Meeting, Jun 29, 2023Kaneka Corporation, Annual General Meeting, Jun 29, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥55.00 per share at 3.3% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 13 June 2023. Payout ratio is a comfortable 17% but the company is not cash flow positive. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).
Reported Earnings • Feb 12Third quarter 2023 earnings released: EPS: JP¥34.87 (vs JP¥111 in 3Q 2022)Third quarter 2023 results: EPS: JP¥34.87 (down from JP¥111 in 3Q 2022). Revenue: JP¥186.5b (up 4.5% from 3Q 2022). Net income: JP¥2.32b (down 68% from 3Q 2022). Profit margin: 1.2% (down from 4.1% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
Price Target Changed • Jan 26Price target decreased by 8.8% to JP¥4,021Down from JP¥4,408, the current price target is an average from 7 analysts. New target price is 19% above last closing price of JP¥3,375. Stock is down 6.3% over the past year. The company is forecast to post earnings per share of JP¥423 for next year compared to JP¥406 last year.
공시 • Dec 17Kaneka Corporation to Report Q3, 2023 Results on Feb 08, 2023Kaneka Corporation announced that they will report Q3, 2023 results on Feb 08, 2023
Price Target Changed • Dec 13Price target decreased to JP¥4,408Down from JP¥4,920, the current price target is an average from 6 analysts. New target price is 31% above last closing price of JP¥3,360. Stock is down 11% over the past year. The company is forecast to post earnings per share of JP¥414 for next year compared to JP¥406 last year.
Board Change • Nov 16Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 9 experienced directors. 2 highly experienced directors. 4 independent directors (8 non-independent directors). Independent Director Yuko Sasakawa was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 11Second quarter 2023 earnings released: EPS: JP¥91.80 (vs JP¥107 in 2Q 2022)Second quarter 2023 results: EPS: JP¥91.80 (down from JP¥107 in 2Q 2022). Revenue: JP¥187.9b (up 13% from 2Q 2022). Net income: JP¥6.05b (down 14% from 2Q 2022). Profit margin: 3.2% (down from 4.2% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥55.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 06 December 2022. Payout ratio is a comfortable 25% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.9%).
Reported Earnings • Aug 12First quarter 2023 earnings released: EPS: JP¥161 (vs JP¥119 in 1Q 2022)First quarter 2023 results: EPS: JP¥161 (up from JP¥119 in 1Q 2022). Revenue: JP¥192.7b (up 17% from 1Q 2022). Net income: JP¥10.5b (up 36% from 1Q 2022). Profit margin: 5.5% (up from 4.7% in 1Q 2022). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 3.2%, compared to a 9.6% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 16Full year 2022 earnings: EPS misses analyst expectationsFull year 2022 results: EPS: JP¥406 (up from JP¥243 in FY 2021). Revenue: JP¥691.5b (up 20% from FY 2021). Net income: JP¥26.5b (up 67% from FY 2021). Profit margin: 3.8% (up from 2.7% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.6%. Over the next year, revenue is forecast to grow 7.3%, compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 8 non-independent directors. Managing Executive Officer & Director Katsunobu Doro was the last director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥60.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 06 June 2022. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.6%).
Reported Earnings • Feb 09Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: JP¥111 (up from JP¥110 in 3Q 2021). Revenue: JP¥178.4b (up 15% from 3Q 2021). Net income: JP¥7.26b (up 1.0% from 3Q 2021). Profit margin: 4.1% (down from 4.6% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Over the next year, revenue is forecast to stay flat compared to a 6.6% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 10Second quarter 2022 earnings released: EPS JP¥107 (vs JP¥31.26 in 2Q 2021)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥166.2b (up 19% from 2Q 2021). Net income: JP¥7.01b (up 244% from 2Q 2021). Profit margin: 4.2% (up from 1.5% in 2Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year and the company’s share price has also fallen by 2% per year.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 07 December 2021. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.9%).
Reported Earnings • Aug 15First quarter 2022 earnings released: EPS JP¥119 (vs JP¥6.70 in 1Q 2021)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: JP¥164.1b (up 30% from 1Q 2021). Net income: JP¥7.76b (up JP¥7.32b from 1Q 2021). Profit margin: 4.7% (up from 0.3% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings.
Price Target Changed • Jul 10Price target increased to JP¥5,056Up from JP¥4,720, the current price target is an average from 5 analysts. New target price is 15% above last closing price of JP¥4,400. Stock is up 71% over the past year.
Reported Earnings • May 16Full year 2021 earnings released: EPS JP¥243 (vs JP¥215 in FY 2020)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: JP¥577.4b (down 4.0% from FY 2020). Net income: JP¥15.8b (up 13% from FY 2020). Profit margin: 2.7% (up from 2.3% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 11 June 2021. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.8%).
Price Target Changed • Mar 06Price target raised to JP¥4,050Up from JP¥3,650, the current price target is an average from 4 analysts. The new target price is 11% below the current share price of JP¥4,535. As of last close, the stock is up 64% over the past year.
Price Target Changed • Mar 02Price target raised to JP¥3,770Up from JP¥3,464, the current price target is an average from 4 analysts. The new target price is 9.8% below the current share price of JP¥4,180. As of last close, the stock is up 46% over the past year.
Is New 90 Day High Low • Feb 24New 90-day high: JP¥4,340The company is up 34% from its price of JP¥3,250 on 26 November 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥2,998 per share.
Major Estimate Revision • Feb 23Analysts update estimatesThe 2021 consensus earning per share (EPS) estimate increased from JP¥164 to JP¥181. Revenue estimate for the same period was approximately flat at JP¥565.9b. Net income is expected to grow by 10.0% next year compared to 17% growth forecast for the Chemicals industry in Japan. The consensus price target increased from JP¥3,464 to JP¥3,650. Share price stayed mostly flat at JP¥4,275 over the past week.
Reported Earnings • Feb 11Third quarter 2021 earnings released: EPS JP¥110 (vs JP¥48.85 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥154.8b (up 1.4% from 3Q 2020). Net income: JP¥7.18b (up 125% from 3Q 2020). Profit margin: 4.6% (up from 2.1% in 3Q 2020). The increase in margin was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Analyst Estimate Surprise Post Earnings • Feb 11Revenue and earnings beat expectationsRevenue exceeded analyst estimates by 4.7%. Earnings per share (EPS) also surpassed analyst estimates by 1.6%. Over the next year, revenue is forecast to grow 3.3%, compared to a 6.5% growth forecast for the Chemicals industry in Japan.
Is New 90 Day High Low • Jan 27New 90-day high: JP¥3,795The company is up 25% from its price of JP¥3,025 on 29 October 2020. The Japanese market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥1,364 per share.
Is New 90 Day High Low • Jan 12New 90-day high: JP¥3,700The company is up 20% from its price of JP¥3,090 on 14 October 2020. The Japanese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is JP¥1,350 per share.